310 related articles for article (PubMed ID: 35291656)
1. Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research.
Kim M; Choe YH; Lee SI
Immune Netw; 2022 Feb; 22(1):e8. PubMed ID: 35291656
[TBL] [Abstract][Full Text] [Related]
2. Towards a stratified targeted approach with biologic treatments in rheumatoid arthritis: role of synovial pathobiology.
Astorri E; Nerviani A; Bombardieri M; Pitzalis C
Curr Pharm Des; 2015; 21(17):2216-24. PubMed ID: 25760296
[TBL] [Abstract][Full Text] [Related]
3. Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis.
Kondo N; Kuroda T; Kobayashi D
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681582
[TBL] [Abstract][Full Text] [Related]
4. Novel Therapeutic Approaches in Rheumatoid Arthritis: Role of Janus Kinases Inhibitors.
Rivellese F; Lobasso A; Barbieri L; Liccardo B; de Paulis A; Rossi FW
Curr Med Chem; 2019; 26(16):2823-2843. PubMed ID: 29424301
[TBL] [Abstract][Full Text] [Related]
5. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].
Bläss S; Engel JM; Burmester GR
Z Rheumatol; 2001 Feb; 60(1):1-16. PubMed ID: 11263010
[TBL] [Abstract][Full Text] [Related]
6. Futuristic Novel Therapeutic Approaches in the Treatment of Rheumatoid Arthritis.
Rai V; Patel N; Mammen SR; Chaudhary SM; Arshad S; Munazzam SW
Cureus; 2023 Nov; 15(11):e49738. PubMed ID: 38161868
[TBL] [Abstract][Full Text] [Related]
7. Deciphering Role of Cytokines for Therapeutic Strategies Against Rheumatoid Arthritis.
Doshi G; Thakkar A
Curr Drug Targets; 2021; 22(7):803-815. PubMed ID: 33109042
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and osteoprotective effects of Chikusetsusaponin Ⅳa on rheumatoid arthritis via the JAK/STAT signaling pathway.
Guo X; Ji J; Zhang J; Hou X; Fu X; Luo Y; Mei Z; Feng Z
Phytomedicine; 2021 Dec; 93():153801. PubMed ID: 34758437
[TBL] [Abstract][Full Text] [Related]
9. Novel Targeted Therapies for Rheumatoid Arthritis Based on Intracellular Signalling and Immunometabolic Changes: A Narrative Review.
Rahmati M; Kwesiga MP; Lou J; Tan AL; McDermott MF
Front Biosci (Landmark Ed); 2024 Jan; 29(1):42. PubMed ID: 38287839
[TBL] [Abstract][Full Text] [Related]
10. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
Kaur S; White S; Bartold M
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.
Biggioggero M; Crotti C; Becciolini A; Favalli EG
Drug Des Devel Ther; 2019; 13():57-70. PubMed ID: 30587928
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Management of Rheumatoid Arthritis: A Review.
Aletaha D; Smolen JS
JAMA; 2018 Oct; 320(13):1360-1372. PubMed ID: 30285183
[TBL] [Abstract][Full Text] [Related]
13. B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.
Nakken B; Munthe LA; Konttinen YT; Sandberg AK; Szekanecz Z; Alex P; Szodoray P
Autoimmun Rev; 2011 Nov; 11(1):28-34. PubMed ID: 21777703
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targets for rheumatoid arthritis: Progress and promises.
Alghasham A; Rasheed Z
Autoimmunity; 2014 Mar; 47(2):77-94. PubMed ID: 24437572
[TBL] [Abstract][Full Text] [Related]
15. Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects.
Crotti C; Agape E; Becciolini A; Biggioggero M; Favalli EG
Drugs; 2019 Nov; 79(16):1741-1755. PubMed ID: 31486005
[TBL] [Abstract][Full Text] [Related]
16. The roles of small-molecule inflammatory mediators in rheumatoid arthritis.
Cheng Q; Wu H; Du Y
Scand J Immunol; 2021 Mar; 93(3):e12982. PubMed ID: 33025632
[TBL] [Abstract][Full Text] [Related]
17. Treatment with Biologicals in Rheumatoid Arthritis: An Overview.
Rein P; Mueller RB
Rheumatol Ther; 2017 Dec; 4(2):247-261. PubMed ID: 28831712
[TBL] [Abstract][Full Text] [Related]
18. Signaling pathways in rheumatoid arthritis: implications for targeted therapy.
Ding Q; Hu W; Wang R; Yang Q; Zhu M; Li M; Cai J; Rose P; Mao J; Zhu YZ
Signal Transduct Target Ther; 2023 Feb; 8(1):68. PubMed ID: 36797236
[TBL] [Abstract][Full Text] [Related]
19. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin.
Raza K; Falciani F; Curnow SJ; Ross EJ; Lee CY; Akbar AN; Lord JM; Gordon C; Buckley CD; Salmon M
Arthritis Res Ther; 2005; 7(4):R784-95. PubMed ID: 15987480
[TBL] [Abstract][Full Text] [Related]
20. The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway.
Wu Q; Wang Y; Wang Q; Yu D; Wang Y; Song L; Liu Z; Ye X; Xu P; Cao H; Li D; Ren G
Immunol Lett; 2016 Nov; 179():68-79. PubMed ID: 27616043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
